Stocks in the News: June 23, 2025 — AI, Biotech, Bitcoin, and Bold M&A Moves Shape the Market
DENVER, Colo., Jun 23, 2025 (247marketnews.com)- Today’s market headlines are dominated by high-impact merger activity, biotech breakthroughs, and bold Bitcoin treasury strategies from public companies eager to capture investor attention and long-term value. Here’s a breakdown of the most compelling news moving stocks:
Core Gaming’s AI App Experiences Rapid Growth in Key Target Markets Ahead of Siyata Merger
Core Gaming, which recently signed a definitive merger agreement with Siyata Mobile (NASDAQ:SYTA), announced significant growth of its flagship AI-powered app, AI COMIC, particularly in key Asian markets. In just under a year, user numbers in Japan and South Korea surged 1,300%, growing from 2,500 to over 32,000 users. These two countries now represent 14.38% of AI COMIC’s global user base, up from just 4.12%, underscoring both market fit and viral adoption.
AI COMIC transforms visuals into anime-style content using features such as AI-generated video, personalized avatars, manga scenes, time-lapse aging, and realistic face swaps. The app has gone viral across TikTok and Facebook, driving rapid organic growth and community engagement.
Under the hood, Core Gaming’s advantage lies in a next-generation AI infrastructure that enables scalable, high-output creativity. The company’s Compute Pool System, multimodal generative models, and proprietary BigP backend give it an edge in streamlining animation, ad creatives, and game asset generation.
As merger completion with Siyata nears, Zacharin confirmed, “We continue to work diligently to finalize the merger with Siyata and remain confident that we will secure regulatory approval in the near future, with closing expected shortly thereafter.”
Dr. Ashleys and Impact BioMedical Join Forces in Strategic Merger
Dr Ashleys Limited and Impact BioMedical (NYSE:IBO) announced a strategic merger that will create a new combined entity, “Dr Ashleys Limited,” to be listed on the NYSE American. The move marks a powerful union of financial strength and biopharmaceutical innovation.
Dr. Kanans Visvanats, Director of Dr. Ashleys Limited, noted, “This merger represents a significant milestone in our journey to bring innovative pharmaceutical treatments to patients worldwide.”
The deal structure includes a reverse merger and share exchange agreement with unified management and a new board. It’s expected to accelerate the commercial pathway for Impact’s pharmaceutical IP portfolio on a global scale.
C&S Wholesale Grocers to Acquire SpartanNash for $1.77 Billion
C&S Wholesale Grocers will acquire SpartanNash (NASDAQ:SPTN) for $26.90 per share in cash, representing a 52.5% premium over the company’s recent share price. The deal, valued at $1.77 billion, aims to boost scale, lower grocery prices, and increase operational efficiencies.
The boards of both companies unanimously approved the transaction, which will combine two major U.S. food distribution networks.
Sequans Communications Launches $384M Bitcoin Treasury Initiative
Sequans Communications (NYSE:SQNS) announced an ambitious $384 million bitcoin treasury initiative, diversifying its financial strategy while staying committed to its core business in 5G/4G IoT semiconductors.
The company will raise capital through:
- $195M in equity securities
- $189M in secured convertible debentures
Sequans also plans to partner with Swan Bitcoin for treasury management, positioning bitcoin as a long-term reserve asset.
The financing is expected to close by July 1, 2025, pending shareholder approval. This makes Sequans one of the latest tech firms joining the wave of bitcoin adoption in corporate treasuries.
ECD Automotive Design Bolsters Bitcoin Strategy with $500M Equity Facility
ECD Automotive Design (NASDAQ:ECDA), known for its luxury Land Rover and Jaguar restorations, signed a $500 million equity facility to fund a bitcoin treasury strategy and future growth initiatives. The company also aims to target crypto-native customers by offering a $21,000 upgrade credit to the first 21 vehicle buyers who pay with Bitcoin.
CFO Ben Piggott stated, “This new initiative reflects our continued confidence in the long-term potential of digital assets and our commitment to creating value for our shareholders and customers.”
ECD’s relationship with BitPay already enables crypto vehicle purchases, but the treasury strategy signals a much deeper crypto integration.
Cidara Therapeutics Reports Strong Phase 2b Results for CD388 Influenza Drug
Cidara Therapeutics (NASDAQ:CDTX) released positive topline results from its Phase 2b trial for CD388, a novel long-acting antiviral for seasonal flu. The drug demonstrated:
- 76% efficacy at the 450 mg dose
- No safety concerns observed
- Statistically significant protection at all three doses over 24 weeks
CEO Jeffrey Stein called the results “unprecedented in influenza,” while CMO Nicole Davarpanah emphasized the drug’s potential for high-risk individuals.
Cidara has submitted a meeting request with the FDA as it prepares for Phase 3 trials. CD388 could be a game-changer for influenza prevention if approved.
Please click here for a Deeper Dive on MAU Valuation Models, or insights from the ValueScope Report.
Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.
For additional 247marketnews.com Siyata disclosure https://247marketnews.com/syta-siyata-mobile-update/
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com